CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 55 filers reported holding CLEARSIDE BIOMEDICAL INC in Q2 2023. The put-call ratio across all filers is 1.30 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1 | -50.0% | 2,000 | 0.0% | 0.00% | – |
Q2 2023 | $2 | 0.0% | 2,000 | 0.0% | 0.00% | – |
Q1 2023 | $2 | 0.0% | 2,000 | 0.0% | 0.00% | – |
Q4 2022 | $2 | -99.9% | 2,000 | 0.0% | 0.00% | – |
Q3 2022 | $2,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
Q2 2022 | $2,000 | -50.0% | 2,000 | 0.0% | 0.00% | – |
Q1 2022 | $4,000 | -20.0% | 2,000 | -4.8% | 0.00% | – |
Q4 2021 | $5,000 | -58.3% | 2,100 | -32.3% | 0.00% | -100.0% |
Q3 2021 | $12,000 | -47.8% | 3,100 | -80.7% | 0.00% | 0.0% |
Q2 2021 | $23,000 | +1050.0% | 16,100 | +1138.5% | 0.00% | – |
Q2 2020 | $2,000 | 0.0% | 1,300 | 0.0% | 0.00% | – |
Q1 2020 | $2,000 | -33.3% | 1,300 | 0.0% | 0.00% | – |
Q4 2019 | $3,000 | – | 1,300 | 0.0% | 0.00% | – |
Q3 2019 | $0 | -100.0% | 1,300 | 0.0% | 0.00% | – |
Q2 2019 | $1,000 | 0.0% | 1,300 | 0.0% | 0.00% | – |
Q1 2019 | $1,000 | 0.0% | 1,300 | 0.0% | 0.00% | – |
Q4 2018 | $1,000 | -98.8% | 1,300 | -91.6% | 0.00% | -100.0% |
Q2 2018 | $84,000 | +833.3% | 15,400 | +1611.1% | 0.01% | +600.0% |
Q1 2018 | $9,000 | – | 900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 169,629 | $147,560 | 0.05% |
BROWN WEALTH MANAGEMENT, LLC | 110,000 | $95,689 | 0.05% |
Carmignac Gestion | 2,132,744 | $1,855,274 | 0.03% |
WATER ISLAND CAPITAL LLC | 82,500 | $72 | 0.01% |
Northeast Financial Consultants Inc | 83,000 | $72,202 | 0.01% |
XTX Topco Ltd | 27,545 | $23,961 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 175,600 | $152,754 | 0.00% |
Curi Wealth Management, LLC | 25,000 | $21,748 | 0.00% |
Banque Cantonale Vaudoise | 40,000 | $35 | 0.00% |
SYNOVUS FINANCIAL CORP | 58,071 | $50,516 | 0.00% |